Operating Lease, Right-of-Use Asset of STANDARD BIOTOOLS INC. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
STANDARD BIOTOOLS INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • STANDARD BIOTOOLS INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $23,453,000, a 23% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

STANDARD BIOTOOLS INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $23,453,000 -$6,811,000 -23% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $24,568,000 -$6,963,000 -22% 30 Jun 2025 10-Q 15 Aug 2025 2025 Q2
Q1 2025 $27,422,000 -$5,544,000 -17% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $26,567,000 -$4,096,000 -13% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $30,264,000 -$927,000 -3% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $31,531,000 -$663,000 -2.1% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $32,966,000 -$8,000 -0.02% 31 Mar 2024 10-Q 09 May 2024 2024 Q3
Q4 2023 $30,663,000 -$3,220,000 -9.5% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $31,191,000 -$3,535,000 -10% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $32,194,000 -$3,218,000 -9.1% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $32,974,000 -$3,415,000 -9.4% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $33,883,000 -$3,236,000 -8.7% 31 Dec 2022 10-K 01 Mar 2024 2023 FY
Q3 2022 $34,726,000 -$2,972,000 -7.9% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $35,412,000 -$3,305,000 -8.5% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $36,389,000 -$856,000 -2.3% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $37,119,000 -$995,000 -2.6% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 $37,698,000 -$771,000 -2% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $38,717,000 -$310,000 -0.79% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $37,245,000 -$2,254,000 -5.7% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $38,114,000 +$33,254,000 +684% 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 $38,469,000 +$33,117,000 +619% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $39,027,000 +$32,521,000 +500% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $39,499,000 +$32,322,000 +450% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $4,860,000 +$4,860,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $5,352,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $6,506,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $7,177,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 27 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.